FIELD: biochemistry, enzymes. SUBSTANCE: invention relates to the use of benzo[1,2-c:3,4-c':5,6-c'']- -tris[1,2,5]-oxadiazole-1,4,7-trioxide as a donor of nitrogen oxide and an activator of the soluble form of guanylate cyclase. This compound is the more effective donor of nitrogen oxide and shows the more expressed effect on guanylate cyclase soluble form as compared with its structural analog. The use of benzo[1,2-c:3,4-c':5,6-c'']-tris[1,2,5] -oxadiazole-1,4,7- -trioxide of the formula (I) expands the assortment of nitrogen oxide donors and specific agents regulating the activity of the soluble guanylate cyclase. EFFECT: broadened assortment of donors and activators.
Title | Year | Author | Number |
---|---|---|---|
SPECIFIC REGULATOR OF ACTIVITY OF NUCLEOTIDE-DEPENDENT ENZYMES | 1997 |
|
RU2130490C1 |
1,2,5-OXADIAZOLO[3,4-D]PYRIDAZINE-5,6-DIOXIDE DERIVATIVES AS ACTIVATORS OF SOLUBLE FORM OF GUANYLATE-CYCLASE AND AGENTS ACTIVE IN TREATMENT OF CENTRAL NERVOUS SYSTEM, AND COMPOSITIONS BASED ON THESE COMPOUNDS | 1997 |
|
RU2165256C2 |
DONOR OF NITROGEN OXIDE AND ACTIVATOR OF GUANYLATE CYCLASE SOLUBLE FORM | 1997 |
|
RU2123046C1 |
DERIVATIVES OF 1,4,2,5-DIOXADIAZINE | 2001 |
|
RU2212409C1 |
DONOR OF NITROGEN OXIDE ACTIVATING SOLUBLE FORM OF GUANYLATE CYCLASE, INHIBITING PLATELET AGGREGATION AND EXHIBITING SPASMOLYTIC AND VASODILATING EFFECT | 2001 |
|
RU2208438C1 |
INCLUSION COMPLEXES OF DERIVATIVES OF 1,2,5-OXA- -DIAZOLE-2-OXIDE WITH POLYCYCLIC DERIVATIVES OF GLUCOPYRANOSE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION | 2001 |
|
RU2186782C1 |
INHIBITOR OF NO-DEPENDENT ACTIVATION OF GUANYLATE CYCLASE SOLUBLE FORM | 2001 |
|
RU2188865C1 |
ACTIVATOR OF GUANYLATE CYCLASE SOLUBLE FORM | 1997 |
|
RU2122582C1 |
INHIBITOR OF NO-DEPENDENT ACTIVATION OF SOLUBLE FORM OF GUANYLATE CYCLASE | 2001 |
|
RU2189392C1 |
INHIBITOR OF GUANYLATE CYCLASE SOLUBLE FORM | 1999 |
|
RU2151799C1 |
Authors
Dates
1999-10-20—Published
1998-08-21—Filed